mPATH Health has secured $3 million in funding to enhance cancer screening and equity.
The funding includes a $2 million Small Business Technology Grant from the National Cancer Institute and a $1 million equity investment led by Oncology Ventures.
mPATH Health aims to improve early cancer detection by utilizing advanced technology and personalized outreach.
The funding will support the commercialization of mPATH's innovative cancer screening program and facilitate the development of new screening and preventive health modules.